Do radiation-induced bystander effects correlate to the intrinsic radiosensitivity of individuals and have clinical significance?

Radiation Research

Volumn 171, Issue 5, 2009, Pages 521-529

  Howe, Orla ^a   O'Sullivan, Jacintha ^b   Nolan, Blathnaid ^b   Vaughan, Joe ^a   Gorman, Sheeona ^a   Clarke, Colin ^a   McClean, Brendan ^c   Lyng, Fiona M ^a  

^a DUBLIN INSTITUTE OF TECHNOLOGY   (Ireland)

^b ST VINCENT S UNIVERSITY HOSPITAL   (Ireland)

^c ST LUKE S HOSPITAL   (Ireland)

Author keywords

[No Author keywords available]

Indexed keywords

ADULT; AGED; ARTICLE; BYSTANDER EFFECT; CANCER RADIOTHERAPY; CHROMOSOME ABERRATION; COLORECTAL CARCINOMA; CONTROLLED STUDY; CORRELATION ANALYSIS; CULTURE MEDIUM; FEMALE; HUMAN; HUMAN CELL; IN VITRO STUDY; MAJOR CLINICAL STUDY; MALE; PRIORITY JOURNAL; RADIOSENSITIVITY; CELL CULTURE; COLORECTAL TUMOR; GENETICS; MIDDLE AGED; RADIATION DOSE; RADIATION EXPOSURE;

ADULT; AGED; AGED, 80 AND OVER; BYSTANDER EFFECT; CELLS, CULTURED; CHROMOSOME ABERRATIONS; COLORECTAL NEOPLASMS; HUMANS; MIDDLE AGED; RADIATION TOLERANCE;

EID: 67650660060     PISSN: 00337587     EISSN: None     Source Type: Journal    
DOI: 10.1667/RR1579.1     Document Type: Article

References (37)

1. D. Twardella and J. Chang-Claude, Studies on radiosensitivity from an epidemiological point of view - overview of methods and results. Radiother. Oncol. 62, 249-260 (2002).
2. I. Turreson, J. Nyman, E. Holmberg and A. Oden, Prognostic factors for acute and late skin reactions in radiotherapy patients. Int. J. Radiat. Oncol. Biol. Phys. 36, 1065-1075 (1996).
3. D. Scott, Chromosomal radiosensitivity and low penetrance predisposition to cancer. Cytogenet. Res. 104, 365-370 (2004).
4. 2 chromosomal radiosensitivity in Irish breast cancer patients: a comparison with other studies. Int. J. Radiat. Biol. 81, 373-378 (2005).
5. O. Howe, K. O'Malley, M. Lavin, R. A. Gardner, C. Seymour, F. Lyng, D. Mulvin, D. M. Quinlan and C. Mothersill, Cell death mechanisms associated with G2 radiosensitivity in patients with prostate cancer and benign prostatic hyperplasia. Radiat. Res. 164, 627-634 (2005).
6. R. Parshad, F. M. Price, V. A. Bohr, K. H. Cowens, J. A. Zujewski and K. K. Sanford, Deficient DNA repair capacity, a predisposing factor in breast cancer. Br. J. Cancer 74, 1-5 (1996).
7. D. Scott, J. P. B. Barber, A. R. Spreadborough, W. Burrill and S. A. Roberts, Increased chromosomal radiosensitivity in breast cancer patients: A comparison of two assays. Int. J. Radiat. Biol. 75, 1-10 (1999).
8. K. Baria, C. Warren, S. A. Roberts, C. M. West and D. Scott, Chromosomal radiosensitivity as a marker of predisposition to common cancers? Br. J. Cancer 84, 892-896 (2001).
9. 2-phase lymphocytes identifies breast cancer patients with a known or putative genetic predisposition. Br. J. Cancer 5, 1157-1161 (2001).
10. A. Baeyens, H. Thierens, K. Claes, B. Poppe, L. Messiaen, L. De Ridder and A. Vral, Chromosomal radiosensitivity in breast cancer patients with a known or putative genetic predisposition. Br. J. Cancer 87, 1379-1385 (2002).
11. 2 chromosomal radiosensitivity in cancer patients: The role of cdk1/cyclin-B activity level in the mechanisms involved. Int. J. Radiat. Biol. 61, 777-784 (2000).
12. C. Mothersill and C. Seymour, Radiation-induced bystander effects: are they good, bad or both? Med. Confl. Surviv. 21, 101-110 (2005).
13. C. Mothersill and C. Seymour, Radiation-induced bystander and other non-targeted effects: novel intervention points in cancer therapy? Curr. Cancer Drug Targets 6, 447-454 (2006).
14. C. Mothersill and C. Seymour, Radiation-induced bystander effects and the DNA paradigm: an "out of field" perspective. Mutat. Res. 597, 5-10 (2006).
15. W. F. Morgan, Non-targeted and delayed effects of exposure to ionizing radiation: I. Radiation-induced genomic instability and bystander effects in vitro. Radiat. Res. 159, 567-580 (2003).
16. W. B. Parsons, C. H. Watkins, G. L. Pease and D. S. Childs, Changes in sternal bone marrow following Roentgen-ray therapy to the spleen in chronic granulocytic leukemia. Cancer 7, 179-189 (1954).
17. L. G. Littlefield, J. G. Hollowell and W. H. Pool, Chromosomal aberrations induced by plasma from irradiated patients: An indirect effect of X-radiation. Radiology 93, 879-886 (1969).
18. G. B. Faguet, S. M. Reichard and D. A. Welter, Radiation-induced clastogenic factors. Cancer Genet. Cytogenet. 12, 73-83 (1984)
19. R. H. Mole, Whole body irradiation-radiobiology or medicine? Br. J. Radiol. 26, 234-241 (1953).
20. M. P. Nobler, The abscopal effect in malignant lymphoma and its relationship to lymphocyte circulation. Radiology 93, 410-412 (1969).
21. J. L. Montour, Abscopal radiation damage to chick thymus and bursa of fabricius. Acta Radiol. Ther. Phys. Biol. 10, 150-160 (1971).
22. K. Camphausen, M. A. Moses, M. A. Menard, M. Sproull, W-D. Beecken, J. Folkman and M. S. O'Reilly, Radiation abscopal antitumor effect is mediated through p53. Cancer Res. 63, 1990-1993 (2003).
23. P. Marozik, C. Mothersill, C. Seymour, I. Mosse and S. Melnov, Bystander effects induced by serum from survivors of the Chernobyl accident. Exp. Hematol. 35, 55-63 (2007).
24. C. Mothersill and C. B. Seymour, Medium from irradiated human epithelial cells but not human fibroblasts reduces the clonogenic survival of unirradiated cells. Int. J. Radiat. Biol. 71, 421-427 (1997).
25. Cancer in Ireland 1994-2005, a summary. Available online at http://www.ncri.ie.
26. F. M. Lyng, P. Maguire, B. McClean, C. Seymour and C. Mothersill, The involvement of calcium and MAP kinase signaling pathways in the production of radiation-induced bystander effects. Radiat. Res. 165, 400-409 (2006).
27. S. M. Nugent, C. E. Mothersill, C. Seymour, B. McClean, F. M. Lyng and J. E. Murphy, Increased mitochondrial mass in cells with functionally compromised mitochondria after exposure to both direct gamma radiation and bystander factors. Radiat. Res. 168, 134-142 (2007).
28. A. M. Vines, F. M. Lyng, B. McClean, C. Seymour and C. E. Mothersill, Bystander signal production and response are independent processes which are cell line dependent. Int. J. Radiat. Biol. 84, 83-90 (2008).
29. J. O Brien, I. Wilson, T. Orton and F. Pognan, Investigation of the Alamar Blue (resazurin) fluorescent dye for the assessment of mammalian cell cytotoxicity. Eur. J. Biochem. 267, 5421-5426 (2000).
30. D. Scott, J. P. B Barber, A. R. Spreadborough, W. Burrill and S. A. Roberts, Increased chromosomal radiosensitivity in breast cancer patients: A comparison of two assays. Int. J. Radiat. Biol. 75, 1-10 (1999).
31. 2-phase assays for human blood lymphocytes as biomarkers of individual sensitivity to ionizing radiation: limitations imposed by intraindividual variability. Radiat. Res. 157, 472-477 (2002).
32. W. F. Morgan, Is there a common mechanism underlying genomic instability, bystander effects and other non-targeted effects of exposure to ionizing radiation? Oncogene 22, 7094-7099 (2003).
33. J. G. Hollowell and L. G. Littlefield, Chromosome aberrations induced by plasma from irradiated patients. A brief report. J. SC Med. Assoc. 63, 437-442 (1967).
34. G. S. Pant and N. Kamada, Chromosome aberrations in normal leucocytes induced by the plasma of exposed individuals. Hiroshima J. Med. Sci. 26, 149-154 (1977).
35. H. Nagasawa and J. B. Little, Induction of sister chromatid exchanges by extremely low doses of alpha particles. Cancer Res. 52, 6394-6396 (1992).
36. C. Mothersill and C. Seymour, Radiation-induced bystander effects: Past history and future directions. Radiat. Res. 15, 759-767 (2001).
37. C. Mothersill, K. J. O'Malley, D. M. Murphy, C. B. Seymour, S. A. Lorimore and E. G. Wright, Identification and characterization of three subtypes of radiation response in normal human urothelial cultures exposed to ionizing radiation. Carcinogenesis 20, 2273-2278 (1999).